bulkactives ghk-cu Peptide GHK-Cu 50mg – Explicit Research
Description
Testing includes quantitative assay verification, heavy metals screening, and comprehensive microbial analysis
The 3D culture medium was xeno-free CMRL 1066-media with the CIT (Clinical Islet Transplant Consortium) modifications with added IGF-1 heparin, and human serum albumin
10.1007/s13361-012-0406-y 13 BagchiD.BagchiM.StohsS
Injectable GHK-Cu requires medical oversight
Dosing starts at 0.25 mg per week, increasing gradually to 1 mg2.4 mg per week as tolerated
Part 1 is the formal application the sponsor submits to the TGA for evaluation
